We are leading a paradigm shift in medicine by using real-world patient data, augmented intelligence and synthetic biology to develop equitable precision medicines.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $15M
Founded date: 2017
Investors 9
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.08.2022 | Seed | $15M | Fifty Year... |
Mentions in press and media 10
| Date | Title | Description |
| 13.11.2025 | Persephone Biosciences Announces Topline Results | from AMBROSIA Food as Medicine Study with Kroger Health |
| 09.09.2025 | Persephone Biosciences Unveils First-Of-Its-Kind | Synbiotic Designed To Restore Critical Gut Microbes In Babies |
| 08.09.2025 | Persephone Biosciences Hits 10,000 Families | on Waitlist for First-of-Its-Kind Infant Synbiotic |
| 24.06.2025 | Milestone Alert: Persephone Biosciences Publishes | First Peer-Reviewed Study |
| 05.06.2023 | Women entrepreneurs are a missed opportunity in venture capital. Here’s how investors and policymakers can change that | Dr. Ashlie L Burkart, MD is the chief scientific officer at Germin8 Ventures, a venture capital firm that impact invests in the food and agricultural domain, and an associate at Harvard Kennedy School’s Belfer Center for Science and Interna... |
| 19.07.2022 | Persephone Biosciences Closes $15M Seed Financing | Persephone Biosciences, a San Diego, CA-based synthetic biology company, raised $15M in Seed funding. The round was led by First Bight Ventures and Propel Bio Partners, with participation from Y Combinator, Fifty Years, Susa Ventures, Ameri... |
| 19.07.2022 | Persephone puts poop to work to explore and heal your gut microbiome | What goes on in that gastrointestinal tract of yours? Well, we have a general idea, but evidence is mounting that the gut and the microbes that live there play an important role in a huge variety of health issues. Persephone is a biotech st... |
| 19.07.2022 | Persephone Biosciences Snags $15M Seed | San Diego-based synthetic biology startup Persephone Biosciences announced today that it has raised $15M in a seed financing round. The funding was co-led by First Bight Ventures and Propel Bio Partners, and also included Y Combinator, Fift... |
| - | Persephone rakes in $15M to support country’s biggest cancer microbiome study | “The microbiome is a new pillar of biology, and it has been historically untapped,” said Stephanie Culler, co-founder and CEO of Persephone Biosciences, in an interview Tuesday. Her company, a preclinical biotech focused on microbiome-based... |
| - | Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics | Bacteroides species are among the most common members of the microbiota of animals, especially in the gastrointestinal tract, and are likely a useful tool for stable and long-term delivery of microbial medicines. Unlike many other gut micro... |